| Clinical data | |
|---|---|
| Other names | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.009.060 |
| Chemical and physical data | |
| Formula | C22H28O5 |
| Molar mass | 372.461 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Prednylidene is aglucocorticoid[1] for systemic use.
Substitution at position 16 also leads to more potent corticosteroids. The additional steric bulk introduced by such substituents adjacent to the dihydroxyacetone side chain also protects that moiety against metabolic degradation.
Thishormonal preparation article is astub. You can help Wikipedia byexpanding it. |